New hope to keep cancer treatment on track: drug aims to fix dangerous platelet drops
NCT ID NCT07408648
Summary
This study is testing a drug called hetrombopag to see if it can safely raise low platelet counts caused by chemotherapy in women with gynecologic cancers. Low platelets can delay or reduce cancer treatment doses. The goal is to help patients complete their planned chemotherapy cycles on time and at full strength by managing this common side effect.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.